Catechin bioavailability enhancer comprising cyclodextrin
US10314915B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2013 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Dec 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.